Neurable, a Boston, Massachusetts-based developer of noninvasive brain-computer interface (BCI) technology designed for everyday life, raised $35m in Series A funding.
The round was led by Spectrum Moonshot Fund, with participation from existing investors including Pace Ventures.
The company intends to use the funds to accelerate the commercialization of Neurable AI, its patented compact brain-signal processing technology, and expand its neurotechnology platform across the broader cognitive health, human performance, and gaming ecosystems.
Led by CEO and co-founder Dr. Ramses Alcaide and VP of Strategic Partnerships Adam Molnar, Neurable develops AI-powered tools for brain signal translation, integrating BCI capabilities into everyday devices.
The company has introduced the MW75 Neuro LT headset, which provides real-time cognitive insights on mental fatigue, recovery, and focus, and has partnered with iMotions and MeSpace for research applications.
Neurable recently partnered with iMotions, a human behavior research platform, integrating its headsets into its software suite and enabling researchers and product teams to capture high-quality neural data at scale. It also collaborated with MeSpace to investigate how adaptive workstations affect cognitive performance.